|
|
Sonendo Inc Outlook |
On May 9 2024 the Sonendo Inc provided following guidance
May 9, 2024 - Sonendo Inc., a prominent dental technology company known for its GentleWave System, released its financial results for the first quarter of 2024. The company reported total revenue of $7.0 million, surpassing the initial guidance of $6.0 million. Sonendo also noted an installed base of 1,142 and a significant increase in console backlog, indicating a strong demand for their products.
In addition to the financial results, Sonendo announced strategic reset priorities to further enhance their position in the market. The company is focused on leveraging their innovative technology to drive growth and expand their customer base. This strategic approach aims to capitalize on the increasing demand for advanced dental technologies and maintain Sonendo's competitive edge in the industry.
Overall, Sonendo's performance in the first quarter of 2024 demonstrates a positive trajectory for the company. With a solid financial outlook and strategic initiatives in place, Sonendo is well-positioned for continued success in the dental technology sector.
|
On March 11 2024 the Sonendo Inc provided following guidance
2022
For the fourth quarter of 2023, Sonendo reported total revenue of $12.3 million, a 3% increase compared to the fourth quarter of 2022. The Company also reported a net loss of $6.8 million for the fourth quarter of 2023.
Looking ahead to full year 2024, Sonendo issued revenue guidance in the range of $50 million to $55 million. This guidance is based on the Company's continued growth in its installed base of GentleWave Systems and anticipated increases in product sales and services.
We are pleased with our financial performance in 2023, as we achieved solid revenue growth and continued to expand our installed base of GentleWave Systems, said Bjarne Bergheim, President and CEO of Sonendo. As we look to 2024, we are confident in our ability to drive further revenue growth and expand our market presence.
In addition to the financial results, Sonendo highlighted some key achievements in 2023, including the successful completion of a clinical trial evaluating the effectiveness of the GentleWave System in root canal therapy. The results of the trial showed that the GentleWave System was highly effective in cleaning and disinfecting root canals, leading to improved patient outcomes.
Overall, Sonendo remains focused on advancing dental technology and providing innovative solutions to improve patient care. With strong financial performance and a promising outlook for 2024, the Company is well-positioned for continued growth and success in the dental technology market.
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.
